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Background: Given recent efforts by the federal government to promote “comparative effectiveness” research, an increasing number of studies 
are likely to be produced comparing alternative treatment strategies from observational data. A number of analytical methods have been used in 
observational studies to compare alternative treatments, including propensity-score (PS) adjustment and instrumental-variable (IV) analysis. We 
explored whether the relative safety of drug-eluting stents (DES) vs. bare metal stents (BMS) was strongly influenced by the analytical method used.
Methods: Kaiser Permanente of Northern California is an integrated health system caring for >3.2 million individuals. All members receiving DES 
or BMS from 1998 to 2006 were included. For the PS analysis, the association between stent type and death at 30 days and 1 year were assessed, 
adjusted for continuous PS, PS decile, and other covariates. For the IV analysis, all procedures occurring before Jan-2003 were assigned to the 
“BMS era” and those after Jan-2004 were assigned to the “DES era.” All analyses included adjustment for outpatient medication use and patient 
comorbidity.
Results: Between 1998 and 2006, 30,880 PCIs with stenting were performed among health plan members (51.3% BMS and 48.7% DES). In the 
PS analysis, DES was associated with a lower rate of mortality at 30-days (OR 0.74, 95% CI 0.63-0.88) and 1-year (OR 0.85, 95% CI 0.76-0.95) 
compared to BMS. However, in the IV analysis, PCI during the DES era (84.1% DES) was not associated with significantly lower adjusted mortality at 
30-days (OR 0.91, 95% CI 0.76 - 1.08) or at 1-year (OR 0.97, 95% CI 0.86 - 1.09) compared with PCI during the BMS era (100% BMS).
Conclusion: Although PS methods suggested a significant mortality benefit with DES, consistent with prior observational studies employing this 
method, an instrumental variable analysis comparing stent era to era failed to support this Conclusion:  Comparative effectiveness research 
generated from observational data must be interpreted with appropriate caution by physicians, hospitals and legislators.
